Oppenheimer Raises CME Group (CME) Price Target, Maintains Outperform Rating
On June 4, Oppenheimer raised its price target on CME Group Inc.
Cme Group Inc. (CME)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 3,594,568 | $953,602,945 | +6% | 0.77% |
| 2. | AQR Capital Management Cliff Asness | 2,783,759 | $735,538,557 | +11% | 0.76% |
| 3. | GuardCap Asset Management Guardian Capital | 2,526,937 | $670,371,117 | -14% | 12.99% |
| 4. | GQG Partners Rajiv Jain | 2,205,041 | $584,975,338 | +7677% | 0.93% |
| 5. | Two Sigma Advisors John Overdeck And David Siegel | 1,998,200 | $530,102,478 | -5% | 1.19% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $262.62 | 12 | $3,041.14 | 2,443 | 2025-03-26 | Filing | |
| $262.62 | 263 | $68,953.51 | 257,061 | 2025-03-26 | Filing | |
| $227.96 | 60 | $13,689.00 | 2,432 | 2025-01-16 | Filing | |
| $227.96 | 1,362 | $310,508.88 | 256,798 | 2025-01-16 | Filing | |
| $232.77 | 8 | $1,802.34 | 1,575 | 2024-12-27 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $265.35 | 350 | $92,872.50 | 4,900 | 2025-06-10 | Filing | |
| $265.36 | 150 | $39,804.00 | 5,250 | 2025-06-10 | Filing | |
| $282.42 | 500 | $141,209.65 | 3,668 | 2025-05-22 | Filing | |
| $277.50 | 390 | $108,225.00 | 6,708 | 2025-05-20 | Filing | |
| $277.88 | 1,060 | $294,552.80 | 3,108 | 2025-05-19 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 34,643,827 | $9,190,660,864 | 0.17% | |
| 2. | 32,605,744 | $8,649,977,749 | 0.18% | |
| 3. | 16,439,164 | $4,361,145,818 | 0.18% | |
| 4. | 12,574,112 | $3,335,786,364 | 0.24% | |
| 5. | 10,562,859 | $2,802,221,300 | 0.2% |
News See All
How will CME Group (CME) Benefit from the Tariffs?
Appalaches Capital, an investment management firm, released its first quarter 2025 investor letter. A copy of the letter can be downloaded here.
Jim Cramer Nailed These 12 Stock Predictions
“I want to pull back the curtain and show you how a professional looks for stocks to buy and knows what to sell. There’s no magic. There’s no hidden talent.
CME Group Inc. (NASDAQ:CME) Q1 2025 Earnings Call Transcript
Adam Minick: Welcome to the CME Group First Quarter 2025 Earnings Call.
10 Stocks on Jim Cramer’s Radar Recently
“What's the deal with these heavy-handed tariffs? Look, I've never been a dogmatic free trader.
10 Best Financial Stocks to Buy According to Billionaires
Financial stocks had a great run in 2024, jumping over 30% by mid-December and outpacing the broader market.
Here’s What Weighed on CME Group’s (CME) Valuation
Parnassus Investments, an investment management company, released the “Parnassus Core Equity Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here.
CME Group Inc. (NASDAQ:CME) Q4 2024 Earnings Call Transcript
Operator: Welcome to the CME Group Fourth Quarter 2024 Earnings Call.
CME Group Inc. (CME): A Bull Case Theory
We came across a bullish thesis on CME Group Inc. (CME) on Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on CME. CME Group Inc.
Billionaire George Soros' Long-Term Stock Picks
George Soros is one of the most influential figures in finance, philanthropy, and global affairs.